MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CTMX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CytomX Therapeutics (CTMX) Ownership - Who owns CytomX Therapeutics?

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
121
Web
https://www.cytomx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
648.75M
P/E Ratio
18.17
Total Cash
346.71M
Projected Growth
N/A
Total Debt
2.86M
Revenue
35.54M
Risk (Beta)
3.85
Dividend Yield
N/A
Total Cash/Share
1.59
Total Debt/Equity
N/A
Revenue/Share
0.22 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CTMX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CTMX
A.I. Advisor
published General Information

General Information

an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
121
Web
https://www.cytomx.com